As of 2025-11-16, the Relative Valuation of Ocugen Inc (OCGN) is (4.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.19 USD, the upside of Ocugen Inc based on Relative Valuation is -466.9%.
The range of the Relative Valuation is (3.34) - (5.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 25.9x | 21.0x |
| Forward P/E multiples | 16.3x - 26.9x | 21.6x |
| Fair Price | (3.34) - (5.31) | (4.37) |
| Upside | -380.8% - -546.2% | -466.9% |
| Date | P/E |
| 2025-11-14 | -5.81 |
| 2025-11-13 | -6.05 |
| 2025-11-12 | -6.54 |
| 2025-11-11 | -6.49 |
| 2025-11-10 | -6.59 |
| 2025-11-07 | -6.63 |
| 2025-11-06 | -6.73 |
| 2025-11-05 | -6.88 |
| 2025-11-04 | -6.98 |
| 2025-11-03 | -7.51 |
| 2025-10-31 | -7.61 |
| 2025-10-30 | -7.22 |
| 2025-10-29 | -7.32 |
| 2025-10-28 | -7.41 |
| 2025-10-27 | -7.61 |
| 2025-10-24 | -7.85 |
| 2025-10-23 | -7.46 |
| 2025-10-22 | -7.37 |
| 2025-10-21 | -7.66 |
| 2025-10-20 | -7.90 |
| 2025-10-17 | -7.81 |
| 2025-10-16 | -7.85 |
| 2025-10-15 | -8.15 |
| 2025-10-14 | -7.95 |
| 2025-10-13 | -7.81 |
| 2025-10-10 | -8.34 |
| 2025-10-09 | -8.93 |
| 2025-10-08 | -8.73 |
| 2025-10-07 | -8.59 |
| 2025-10-06 | -8.88 |
| 2025-10-03 | -8.63 |
| 2025-10-02 | -8.63 |
| 2025-10-01 | -8.20 |
| 2025-09-30 | -7.95 |
| 2025-09-29 | -7.07 |
| 2025-09-26 | -7.12 |
| 2025-09-25 | -7.41 |
| 2025-09-24 | -8.00 |
| 2025-09-23 | -8.10 |
| 2025-09-22 | -6.78 |
| 2025-09-19 | -6.54 |
| 2025-09-18 | -6.83 |
| 2025-09-17 | -6.44 |
| 2025-09-16 | -5.71 |
| 2025-09-15 | -5.85 |
| 2025-09-12 | -5.22 |
| 2025-09-11 | -5.22 |
| 2025-09-10 | -5.07 |
| 2025-09-09 | -5.02 |
| 2025-09-08 | -5.02 |